This post will be closed automatically in 2026-10-23 23:17
Reward30points
journalㄩJACC
AuthorsㄩDong Huang; Hongxian Wu; Yuan Lu; Qingjun Liu; Haipeng Cai; Jieyan Shen; Likun Ma; Zongliang Yu; Shuguang Zhao; Shenghu He; Wenhui Peng; Jinyuan Zhang; Juying Qian; Junbo Ge; Yuan Lu; Qingjun Liu; Haipeng Cai; Jieyan Shen; Likun Ma; Zongliang Yu; Shuguang Zhao; Shenghu He; Wenhui Peng; Haijun Zheng; Mingliang Wang; Hongyu Shi; Qi Wu; Yuquan He; Yansong Li; Haibo Liu; Chunguang Feng; Tao Liu; Wenbing Jiang; Xudong Yu; Junming Li; Lun Li; Zhenyu Yang; Yong Guo; Jianhong Tao; Qiong Zhang; Jun Luo; Yanqing Wu; Jiangfang Lian; Jianling Chen; Shaowei Zhuang; Jiyong Jin; Zhen Zhang; Huan Zhang; Bin Ning; Hao Zhou; Caidong Luo; Xiaogang Guo; Yongtai Gong; Bo Wu; Zeqi Zheng; Shuai Jiang; Lianpin Wu; Rugang Huang; Jianxiong Liu; Xiaoyan Wang; Hongbo Liu; Banglong Xu; Junbo Ge
Published dateㄩ2026-9-
DOIㄩ10.1016/j.jacc.2026.07.005
PDF linkㄩhttps://www.sciencedirect.com/sc ... 735109726070713/pdf
Article linkㄩhttps://doi.org/10.1016/j.jacc.2026.07.005
Article SourceㄩElsevier BV﹝
Remarkㄩ |
Best Answer
40
Efficacy and safety of onradivir in adults with acute uncomplicated influenza A infection in China: a multicentre, double-blind, randomised, placebo-controlled and oseltamivir-controlled, phase 3 trial
